Enhancing Access and Affordability of Life-Saving Anaphylaxis Treatment
Background:
Epinephrine self-injection is a life-saving therapy used by many. Affordability of these regimens vary, and the products have historically been impacted by low market availability. We understand the critical nature surrounding the need for this product in the marketplace and strive to encourage prescribing of affordable versions. It is important that members in need of this drug have it on hand and cost should not be a barrier to accessibility.
Opportunity:
We identified a member using a brand-name injection solution. It was a higher cost option for the member compared to generic Epinephrine Auto-Injectors.
Result:
Though the member had filled the brand medication twice, they had ten more refills. Our pharmacy team discussed the economics of the regimen with the prescriber, and they agreed to rewrite the remaining refills for the generic.
Savings:
Annual Client Savings: $6,700
Annual Member Savings: $540
Want to see how you could save? Contact us for an ROI guarantee proposal to see.
Results may vary based on formulary design. Past results do not guarantee future results.